LifeMD, Inc. (LFMDP) EBIT Margin (2012 - 2025)
LifeMD's (LFMDP) quarterly EBIT Margin came in at 87.9% in Q4 2025, up 2089.0% YoY from 4.02% in Q4 2024, and down 2585.84% on a QoQ basis from 3.27% in Q3 2025.
LifeMD, Inc. (LFMDP) EBIT Margin (2012 - 2025) Analysis & Trends
LifeMD (LFMDP) has 14 years of EBIT Margin data on file, last reported at 87.9% in Q4 2025.
- Quarterly EBIT Margin rose 2089.0% year-over-year to 87.9% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 3.49% (up 1112.0% YoY) and the FY2025 annual result came in at 3.95%, up 923.0% from the prior year.
- EBIT Margin declined to 87.9% in Q4 2025, from 3.27% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 416.36% in Q2 2025 to a low of 108.78% in Q4 2024.
- A 5-year average of 11.86% and a median of 18.24% in 2022 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2024 — EBIT Margin plunged 10394 bps — and 2025, when it surged 42881 bps.
- Tracing LFMDP's EBIT Margin over 5 years: stood at 49.84% in 2021, then increased by 26 bps to 36.88% in 2022, then jumped by 87 bps to 4.84% in 2023, then slumped by 2147 bps to 108.78% in 2024, then advanced by 19 bps to 87.9% in 2025.
- The last three EBIT Margin figures came in at 87.9% (Q4 2025), 3.27% (Q3 2025), and 416.36% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -87.90% |
| Sep 30, 2025 | -3.27% |
| Jun 30, 2025 | 416.36% |
| Mar 31, 2025 | 4.24% |
| Dec 31, 2024 | -108.78% |
| Sep 30, 2024 | -7.50% |
| Jun 30, 2024 | -12.45% |
| Mar 31, 2024 | -13.98% |
| Dec 31, 2023 | -4.84% |
| Sep 30, 2023 | -11.83% |
| Jun 30, 2023 | -13.62% |
| Mar 31, 2023 | -8.61% |
| Dec 31, 2022 | -36.88% |
| Sep 30, 2022 | -22.49% |
| Jun 30, 2022 | -42.37% |
| Mar 31, 2022 | -45.13% |
| Dec 31, 2021 | -49.84% |
| Sep 30, 2021 | -50.47% |
| Jun 30, 2021 | -72.27% |
| Mar 31, 2021 | -65.49% |